Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

In this case report, we provide evidence for the possibility of red blood cell alloimmunization after bone-allograft transplantation. Here, we present a 13-year-old boy who received a bone allograft due to impending hip-luxation. Five months later he was shown to have developed three different alloantibodies: anti-D, anti-C and anti-E, which were induced by the bone allograft. Red blood cell alloimmunization is a possible adverse event when a patient is exposed to allogenic red blood cells. These antibodies may cause transfusion reactions when incompatible blood is administered. More importantly, these antibodies may cause severe, or even fatal, hemolytic disease of the fetus or newborn, stretching the importance of preventing antibody formation, especially in young women. This case demonstrates the importance of selecting rhesus phenotype compatible bone allografts. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Citation

L Prinzen, H M Staal, S J M Rouwette, E A M Beckers, R H M ten Broeke, L W van Rhijn, Y M C Henskens. Triple red blood cell alloantibody formation after bone-allograft transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2013 Jan;13(1):229-31

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 23094701

View Full Text